# Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

> **NCT02992652** · NA · COMPLETED · sponsor: **Ain Shams University** · enrollment: 100 (actual)

## Conditions studied

- Endoscopic Retrograde Cholangiopancreatography

## Interventions

- **DRUG:** Allopurinol

## Key facts

- **NCT ID:** NCT02992652
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992652, "Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02992652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*